Mercado de bioinformática en América del Norte: tendencias de la industria y pronóstico hasta 2029

Análisis y perspectivas del mercado de bioinformática en América del Norte

Los factores que impulsan el crecimiento del mercado de la bioinformática son el menor coste de la secuenciación genética por base, la creciente necesidad de bioinformática, la amplia cartera de productos que ofrecen los principales actores del mercado y el uso de la bioinformática en la medicina personalizada, así como el aumento de la financiación de los sectores público y privado para la bioinformática. Sin embargo, los factores que se espera que limiten el crecimiento del mercado son el aumento del coste de la instrumentación, la dificultad del análisis bioinformático clínico y la ciberseguridad en la bioinformática.

Por otra parte, las iniciativas estratégicas de los actores del mercado, el desarrollo de productos, los avances en la tecnología bioinformática y el aumento del gasto sanitario pueden actuar como una oportunidad para el crecimiento del mercado de la bioinformática. Sin embargo, la necesidad de conocimientos especializados, los desafíos en la implementación de la tecnología bioinformática en los laboratorios clínicos y la aprobación regulatoria pueden crear desafíos para el mercado de la bioinformática. Hay desarrollos recientes relacionados con el mercado mundial de la bioinformática.

Se espera que la creciente demanda del uso de la bioinformática en el desarrollo y diseño de fármacos impulse el crecimiento del mercado en América del Norte. Data Bridge Market Research analiza que el mercado de la bioinformática en América del Norte crecerá a una tasa compuesta anual del 21,8 % durante el período de pronóstico de 2022 a 2029.

Market Definition

Bioinformatics combines computer programming, big data, and Molecular Biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.

From genetics to toxicology to mycology and radiobiology, there are scores of branches of Biology to specialize in. And out of the many, Bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of Computer Science, Statistics, and Biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, etc.

In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand the biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify quality targets

North America Bioinformatics Market Dynamics

Drivers

• Decrease in The Cost of Genetic Sequencing Per Base

Oral health is one of the most important aspects of maintaining the health of gums, teeth and the oral-facial system, which allows for speaking, chewing and smiling. According to World Health Organization's report on March 25th, 2020, around 2.3 billion people worldwide are suffering from caries of a permanent tooth, among which around 530 million children suffer from caries of the primary tooth. In North America, periodontal disease has a high prevalence among all age groups. Thereby due to rising periodontal dental disorders, the availability and usage of intraoral scanners are anticipated to boost the market's growth.

• Growing Need for Bioinformatics

As genomics-focused pharmacology continues to play a greater role in the treatment of various chronic diseases, especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumors and specific receptors. Informatics is essential in biological research involving biologists who learn programming, computer programmers, mathematicians, or database managers who learn the foundations of biology.

Opportunities

• Product Development in Recent Years

The growth curve for  bioinformatics market clinical applications is following an upward trend as established applications are gaining momentum and new ones are finding a foothold. Product development in the past years has helped the market size to grow. This also shows the support of the regulatory agency for allowing these products in the market.

For instance-

• In June 2021, Agilent Technologies, Inc. released a new exome design called Sure Select Human All Exon V8 that offers specific content and current coverage of protein-coding areas from Refuses, CCDS and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which are neglected by competing exomes

The product development in recent years has shown the potential of these technologies and the companies working in this market are trying to get the more advanced product in the market, which is expected to create a lucrative opportunity for market growth in the forecast period.

• Strategic Initiatives by Market Players

The demand for bioinformatics is increasing in the market owing to the increased levels of research and development along with the growth of the bioinformatics services market aided by the desire for innovative medications. Thus, the top market players have implemented a new strategy by developing new products and collaborating with other market players to improve business operations and profitability.

For instance-

• In January 2020, Charles River underwent a strategic alliance with FiOS Genomics to acquire knowledge in bioinformatics, statistics and biology to help with the collection and analysis of high-dimensional, multi-variant datasets related to drug development, such as microarrays, next-generation sequencing (NGS), proteomics, metabolomics and epigenetics, as well as the related meta-data

These strategic initiatives by the market players, including acquisition, conferences and focused segment product launches, are helping them grow and improve the company's product portfolio, ultimately leading to more revenue generation. Hence, these strategic initiatives by the market players may be expected to as an opportunity that is expected to drive market growth.

Restraints/Challenges

• Difficulty in Clinical Bioinformatics Analysis

The largely untapped potential of big data analytics is a feed buzz that has been exacerbated by the production of many next-generation data sets that seek to answer long-standing questions about the biology of human diseases. Although these approaches are likely to be a powerful means of unveiling new biological insights, several significant challenges currently hinder efforts to harness the power of big data. Typical challenges include the effective assessment of analytical software tools, the speeding up of the overall process using hybrid parallel computing (HPC) parallelization and acceleration technology, the advancement of automation strategies, data storage alternatives, and, finally, the development of new methods for the full utilization of results across multiple experimental conditions.

• Challenges to Implementing Bioinformatics Technology in The Clinical Labs

Bioinformatics technologies can perform massively complicated biological data analysis. This capacity simultaneously facilitates the computational tools for the organization and analysis of biological data, which helps improve diagnostic screening. The application of these powerful technologies in a clinical laboratory poses a challenge because of the data's scope, quantity and medico-technical consequences.

Various challenges of implementing next-generation sequencing in the clinical laboratory are as follows-

• One of the first areas where problems can creep in is often the most overlooked: "sample quality". Although platforms are often tested and compared using highly curated samples (such as the reference material from the Genome in a Bottle Consortium), real-world samples often present much more of a challenge and hence act as a challenge for the rise in demand
• High turn-around time is also a major challenge for the instruments working in this market

COVID-19 Impact on the North America Bioinformatics Market

During the pandemic, the North Bioinformatics sector is one that focuses on using a combination of biology and information technology. At the heart of the industry is biological data, which is analyzed and transformed using IT techniques. Bioinformatics has always had huge potential in providing essential support to many areas of scientific research. The tools that Bioinformatics can provide allow scientists to get to grips with larger data sets and to mine and analyze them to discover crucial information that could lead to key discoveries. Genetics and genomes have been the primary focus of Bioinformatics in recent years, including comparative genomics, DNA microarrays, and functional genomics.

Recent Developments

• In March 2022, Thermo Fisher Scientific Inc launched the CE-IVD Marked Next-Generation Sequencing (NGS) Instrument for Use in Clinical Labs. The CE-IVD Marked Next-Generation Sequencing Instrument is used to perform diagnostic testing and clinical research on a single instrument. The launch of the instrument resulted in the addition of a new product in the product range and the distribution of the NGS instrument, which is expected to increase the product revenue.

North America Bioinformatics Market Scope

North America bioinformatics market is segmented on the basis of six segments: type, sector, application, purchase mode, genomics, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Knowledge Management Tools
• Bioinformatics Software
• Services

On the basis of type, the North America bioinformatics market is segmented into knowledge management tools, bioinformatics software, and services.

Sector

• Medical biotechnology
• Academics
• Animal Biotechnology
• Agricultural biotechnology
• Environmental Biotechnology
• Forensic biotechnology
• Others

On the basis of sector, the North America bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others.

Application

• Genomics and Drug Development
• Proteomics
• Evolutionary Studies
• Agricultural Studies
• Veterinary Science
• Metabolomics
• Transcriptomics
• Others

On the basis of application, the North America bioinformatics market is segmented into genomics and drug development, proteomics, evolutionary studies, agricultural studies, veterinary science, metabolomics, transcriptomics, and others.

Purchase Mode

• Group Purchase
• Individual Purchase

On the basis of purchase mode, the North America bioinformatics market is segmented into group purchases and individual purchases.

Method

• Genomics
• Proteomics

On the basis of method, the North America bioinformatics market is segmented into genomics and proteomics.

End User

• Research and Academic Institutes
• Clinical Research Organization
• Biotech and Pharmaceutical Companies
• Research Laboratories
• Hospital
• Others

On the basis of end-user, the North America Bioinformatics market is segmented into research and academic institutes, clinical research organizations, biotech and pharmaceutical companies, research laboratories, hospitals, and others.

Pipeline Analysis

North America Bioinformatics Market Regional Analysis/Insights

North America bioinformatics market is analyzed, and market size insights and trends are provided by regions, type, sector, application, purchase mode, genomics, and end-user. as referenced above.

Los países incluidos en el informe sobre el mercado de bioinformática en América del Norte son Estados Unidos, Canadá y Nuevo México. Se espera que Estados Unidos domine el mercado debido al aumento de la incidencia de enfermedades periodontales, el aumento del turismo médico, el crecimiento de las innovaciones tecnológicas en bioinformática y el aumento de la actividad de investigación y desarrollo.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en las regulaciones en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Los puntos de datos como nuevas ventas, ventas de reemplazo, demografía del país, epidemiología de enfermedades y aranceles de importación y exportación son algunos de los principales indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas y sus desafíos enfrentados debido a la gran o escasa competencia de las marcas locales y nacionales que impactan en los canales de venta se consideran al proporcionar un análisis de pronóstico de los datos del país.

Análisis del panorama competitivo y de la cuota de mercado de la bioinformática en América del Norte

El panorama competitivo del mercado de bioinformática de América del Norte proporciona detalles sobre el competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia en América del Norte, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de bioinformática de América del Norte.

Algunos de los principales actores que operan en el mercado de bioinformática de América del Norte son Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Water Corporation, Partek Incorporated, DNASTAR, Dassault Systèmes, Bayer AG, DNANEXUS, INC., PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, GenoFAB, Inc. entre otros.

SKU-1843